Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-02-04

Clinical Trial Update: Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating pre-emptive pregabalin to attenuate maternal anxiety and stress response to intubation during cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Zagazig University | Conditions: Anxiety State, Sedation | Phase 1, Phase 2 | Status: UNKNOWN